Clinical Trial Update: Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetics study comparing JT1801 with NESP after a single dose in healthy Chinese male volunteers completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Anemia

Drugs mentioned

• JT1801
• NESP

Snippet

Sponsor: Yi Fang | Conditions: Renal Anemia | Phase 4 | Status: COMPLETED